Literature DB >> 16637040

End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulation.

Diana Apetauerova1, R Kevin Ryan, Susie I Ro, Jeffrey Arle, Jay Shils, Efstathios Papavassiliou, Daniel Tarsy.   

Abstract

We report the therapeutic effects of deep brain stimulation (DBS) in 2 patients with Parkinson's disease (PD) with severe end of dose dyskinesia that was resistant to medical therapy. In both patients, severe, end of day ballistic dyskinesias occurred when the last levodopa dose of the day was wearing off. Globus pallidus (GPi) DBS in 1 case and subthalamic (STN) DBS in the second case produced full resolution of end of day dyskinesia. (c) 2006 Movement Disorder Society

Entities:  

Mesh：

Year:  2006        PMID： 16637040     DOI： 10.1002/mds.20896

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  5 in total

1.  Pre-Clinical Development of Robot-Assisted Ventriculoscopy for 3D Image Reconstruction and Guidance of Deep Brain Neurosurgery.

Authors:  Prasad Vagdargi; Ali Uneri; Craig K Jones; Pengwei Wu; Runze Han; Mark G Luciano; William S Anderson; Patrick A Helm; Gregory D Hager; Jeffrey H Siewerdsen
Journal:  IEEE Trans Med Robot Bionics       Date:  2021-11-13

2.  Reply to Comment on: Successful Treatment of Levodopa/Carbidopa Intestinal Gel Associated "Biphasic-Like" Dyskinesia with Pallidal Deep Brain Stimulation.

Authors:  Eoin Mulroy; Valentina Leta; Ludvic Zrinzo; Thomas Foltynie; Kallol Ray Chaudhuri; Patricia Limousin
Journal:  Mov Disord Clin Pract       Date:  2021-04-26

3.  Characterizing Deep Brain Stimulation effects in computationally efficient neural network models.

Authors:  Alberta Latteri; Paolo Arena; Paolo Mazzone
Journal:  Nonlinear Biomed Phys       Date:  2011-04-15

4.  The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats.

Authors:  Asier Aristieta; Garikoitz Azkona; Ainhoa Sagarduy; Cristina Miguelez; José Ángel Ruiz-Ortega; Rosario Sanchez-Pernaute; Luisa Ugedo
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

Review 5.  Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?

Authors:  Jean-François Daneault; Benoit Carignan; Abbas F Sadikot; Michel Panisset; Christian Duval
Journal:  BMC Med       Date:  2013-03-20       Impact factor: 8.775
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.